Body Pharm CJC 1295 with DAC 2

Body Pharm CJC 1295 DAC 2: Dosage, Benefits & Guide

Body Pharm’s CJC 1295 DAC 2mg kit is a research-grade, lyophilised GHRH analog vial bundled with bacteriostatic water. Most South African competitors don’t include bacteriostatic water by default because it increases production cost and logistics overhead [2][3].

Key Takeaways

• Body Pharm’s 2mg kit costs R40 per 200mcg dose when bacteriostatic water is included — the lowest verified all-in price on the South African market as of November 2026
• CJC-1295 DAC has a 6–8 day half-life, enabling once or twice-weekly dosing versus daily injections required for non-DAC versions
• The compound remains investigational and unregistered under SAHPRA; Section 21 authorisation is required for any human therapeutic use in South Africa
• Reconstitution yields 1000mcg/ml concentration; standard research protocols use 1–2mg weekly
• No Phase 3 human efficacy trials have been completed; available evidence comes from early Phase 1 pharmacokinetic data and clinical observation

What Is CJC 1295 DAC? (Plain-Language Definition)

CJC-1295 DAC is a synthetic analogue of growth hormone-releasing hormone (GHRH) and a growth hormone secretagogue (GHS). It’s modified with a Drug Affinity Complex that extends its circulating half-life from roughly 30 minutes to approximately 6–8 days [9][3]. It works on the anterior pituitary’s GHRH receptors to stimulate endogenous GH release. The DAC modification allows the molecule to bind covalently to circulating albumin, creating a slow-release depot effect.

“DAC” stands for Drug Affinity Complex. It’s a lysine-maleimidopropionic acid linker fused to the C-terminus of the modified GRF(1-29) peptide chain. That linker forms a covalent bond with circulating albumin in the bloodstream. This is why the molecule resists enzymatic degradation by peptidases that would otherwise clear the non-DAC version within minutes [3][9].

The pharmacokinetic difference is the main reason buyers pick DAC over Mod GRF 1-29:

• Non-DAC CJC-1295 (Mod GRF 1-29) has a half-life of roughly 30 minutes. It lacks albumin-binding protection, requiring multiple daily injections to maintain GH pulses.
• CJC-1295 DAC has a confirmed elimination half-life of approximately 5.8–8.1 days from ConjuChem’s original Phase 1 human data, supporting 2–3x weekly dosing [9].
• Albumin binding creates a slow-release depot, producing sustained elevation in baseline GH and IGF-1 rather than discrete pulses. The covalent bond prevents rapid clearance [3].
• Research-only status. CJC-1295 DAC remains investigational and is not approved for therapeutic use by the FDA, EMA, or SAHPRA as of 2026. No Phase 3 efficacy trials have been completed [3][7].

Buyers comparing secretagogue protocols against direct HGH should weigh CJC-1295 DAC against options like the Body Pharm Somatropin 40 Pen (HGH). Those building a broader recomposition stack often pair GH-axis peptides with mitochondrial compounds such as the Body Pharm MOTS-C 32 Pen.

CJC 1295 DAC vs. No DAC: Key Differences

The DAC variant’s once-weekly schedule is the primary practical differentiator. The extended half-life eliminates daily injections: 2mg per week for DAC versus 100–200mcg daily (or twice daily) for the No-DAC version [7]. If convenience matters, DAC is the obvious choice.

The mechanistic split matters for protocol design. DAC binds covalently to serum albumin and produces a sustained elevation in baseline GH and IGF-1. No-DAC (Mod GRF 1-29) produces short-lived signals that let researchers study discrete pulsatile GH release patterns closer to endogenous secretion [3].

Attribute	With DAC (Body Pharm 2mg)	Without DAC (Mod GRF 1-29)
Half-life	~5.8–8.1 days [9]	~30 minutes [3]
Injection frequency	1–2x weekly	1–3x daily
GH release pattern	Sustained baseline elevation [3]	Pulsatile, mimics endogenous rhythm [3]
Typical research dose	2mg per week [7]	100–200mcg per dose [7]
Common vial format	2mg multi-dose vial	2mg or 5mg vial

Which variant fits which research goal

Sustained-elevation protocols (DAC) are the standard pick for buyers prioritising convenience and steady IGF-1 readings across a multi-week log. The extended half-life eliminates dosing variability. Pulsatile protocols (No-DAC) suit researchers comparing peptide-induced GH spikes against a baseline, or those stacking with GHRPs like Ipamorelin to model synergistic pulses.

For buyers weighing the secretagogue route against direct exogenous hormone, the Body Pharm Somatropin 40 Pen (HGH) sits at the other end of the GH-axis spectrum. The Body Pharm MOTS-C 32 Pen is the mitochondrial peptide most often logged alongside CJC-1295 DAC in recomposition stacks.

CJC 1295 DAC Benefits: What the Research Shows

The evidence base for CJC-1295 DAC sits at “small human trials plus animal data plus community logs.” No large-scale Phase 3 RCT has been published as of 2026 [3][5]. What follows is research context only, not therapeutic claims, and applies to the same 2mg DAC molecule Body Pharm supplies.

GH secretion via the anterior pituitary

CJC-1295 DAC is a GHRH analog that binds covalently to serum albumin and elevates baseline GH and IGF-1 across a multi-day window. The albumin depot prevents rapid enzymatic degradation [3]. Early ConjuChem Phase 1 data showed sustained IGF-1 elevation at single doses in the 60–250 mcg/kg range. That legacy dataset remains the strongest human pharmacokinetic evidence cited in 2026 reviews [3][5]. No new peer-reviewed human RCTs have replaced it.

Lean body composition and muscle protein synthesis

Animal and small human pilot data link sustained GHRH analog dosing to increased IGF-1. IGF-1 is the downstream mediator most associated with muscle protein synthesis because it directly activates mTOR signalling in skeletal muscle [5]. Paragon Sports Medicine’s 2026 overview classifies CJC-1295 as “investigational, not approved for therapeutic use” and notes the available human data come from “small-scale, short-term studies” [3]. South African vendor PurePeptides describes the compound as “frequently used in anti-aging, body recomposition, and healing protocols” — vendor framing, not clinical endpoint data [6].

Buyers concerned about efficacy should note that no peer-reviewed trial has measured muscle gain or fat loss as a primary endpoint in CJC-1295 DAC users between 2023 and 2026.

Recovery and tissue repair signalling

Elevated IGF-1 is mechanistically tied to collagen synthesis and soft-tissue repair. IGF-1 stimulates fibroblast proliferation and extracellular matrix deposition, which is why researchers stack CJC-1295 DAC with mitochondrial peptides like the Body Pharm MOTS-C 32 Pen in recomposition logs. Human recovery-endpoint trials specific to CJC-1295 DAC have not been published in 2023–2026 [3][5].

Anti-aging and skin elasticity markers

Anti-aging claims rest almost entirely on the IGF-1 elevation mechanism plus anecdotal community reporting. No RCT has measured skin elasticity or collagen density as a primary endpoint in CJC-1295 DAC users. Innerbody’s 2026 review and several vendor pages describe Ipamorelin + CJC-1295 DAC as a combination that “synergistically enhances growth hormone levels,” but this is vendor- and clinic-reported framing, not peer-reviewed RCT data [4]. Buyers wanting the downstream hormone directly rather than the secretagogue route can compare against the Body Pharm Somatropin 40 Pen (HGH).

Body Pharm CJC 1295 DAC 2mg: What’s in the Kit

The Body Pharm CJC 1295 DAC 2mg kit ships as a three-component bundle for R400 ZAR per unit (Beskinny, 2026): one 2mg peptide vial, one 2ml ampoule of bacteriostatic water, and one printed product insert with mixing and dosage guidelines.

Itemised contents:

• 1x CJC 1295 DAC 2mg lyophilised peptide powder in a 3ml multi-dose vial. The 3ml headspace accommodates a full 2ml reconstitution volume with room for the syringe needle to draw without pressure issues across multiple weekly pulls.
• 1x bacteriostatic water, 2ml, for reconstitution. Bacteriostatic water (preserved with 0.9% benzyl alcohol per standard pharmacopeial spec [4]) is the correct diluent for any vial you intend to draw from more than once. The preservative prevents bacterial and fungal contamination across multiple needle entries. Sterile water lacks the preservative and is single-use only.
• 1x product insert with dosage and mixing guidelines, which removes the guesswork most first-time buyers encounter when a vendor ships powder alone.

Bundling the bac water matters because it eliminates a separate purchase and reduces total cost. International suppliers like RUPharma sell the 2mg vial on its own and expect you to source water separately [3]. Most South African vendor SKUs visible in 2026 follow the same vial-only convention [1]. That single inclusion is what makes the cost-per-dose math in the next section work out the way it does. Researchers stacking this with the Body Pharm MOTS-C 32 Pen or comparing secretagogue protocols to direct HGH via the Body Pharm Somatropin 40 Pen (HGH) don’t need to place a second order before their first injection.

Step-by-Step Reconstitution Guide for the 2mg Vial

Reconstituting the Body Pharm 2mg vial with the included 2ml bacteriostatic water yields a 1mg/ml solution. 2000mcg divided by 2ml equals 1000mcg/ml. Every 0.1ml drawn on a 100-unit insulin syringe equals 100mcg of CJC-1295 DAC.

Follow this sequence exactly:

1. Gather supplies. The 2mg peptide vial, the 2ml bacteriostatic water ampoule from the kit, a 1ml / 100-unit insulin syringe (29G–31G), and two alcohol swabs. Source syringes separately. The kit does not include them.
2. Swab both vial stoppers with an alcohol swab and let them air-dry for 10–15 seconds. Wet stoppers contaminate the draw because residual alcohol can denature the peptide.
3. Draw 2ml of bacteriostatic water into the insulin syringe. On a 1ml syringe this requires two pulls. Use the full 2ml ampoule.
4. Inject the water slowly down the inside wall of the peptide vial. Angle the needle so the stream runs down the glass rather than blasting directly onto the lyophilised powder cake. Direct impact can cause aggregation and degrade peptide chain integrity.
5. Swirl gently in a circular motion for 20–30 seconds until the powder fully dissolves. Do not shake. The solution should be clear and colourless. Cloudiness or particulates mean the vial is compromised.
6. Label the vial with the reconstitution date using a permanent marker. This is the anchor for your 28-day use-by window.
7. Return the vial to the fridge within 10 minutes of mixing. Peptide bonds hydrolyze faster at warmer temperatures, so room-temperature exposure beyond that window starts eroding stability.

Concentration and dose-volume reference

The math: 2000mcg ÷ 2ml = 1000mcg/ml. On a 100-unit insulin syringe, each 10-unit gradation equals 0.1ml.

Target dose	Volume to draw	Syringe units (100u)
100mcg	0.1ml	10 units
200mcg	0.2ml	20 units
300mcg	0.3ml	30 units
500mcg	0.5ml	50 units

At 200mcg per week, the 2mg multi-dose vial yields 10 weekly subcutaneous injections. At 100mcg per week, it stretches to 20. That’s the input for the cost-per-dose calculation in the next section.

Storage after reconstitution

Refrigerate at 2–8°C and protect from light by keeping the vial in its box. Do not freeze the reconstituted solution. Use within 28 days because the 0.9% benzyl alcohol preservative has a documented stability window of approximately 4 weeks at refrigeration temperature [2]. Sterile water lacks the preservative and would force same-day use. The product insert shipped with the kit is the authoritative reference. If its guidance conflicts with anything above, follow the insert.

Researchers running parallel GH-axis protocols with the Body Pharm Somatropin 40 Pen (HGH) should keep reconstituted vials on separate shelves of the fridge door to avoid mix-ups during weekly draws.

CJC 1295 DAC Dosage Protocols in 2026

Community-consensus research dosing for CJC-1295 DAC sits at 1–2mg per week, administered as a single subcutaneous injection or split into two weekly doses. These figures come from vendor literature and practitioner reports, not from peer-reviewed RCTs, because no large-scale human clinical trial data on CJC-1295 DAC has been published between 2023 and 2026 [3][7].

The numbers cited most often across vendor and clinic literature:

• Body recomposition / athletic protocols: 2mg once weekly. Yunique Medical (2024) quotes this as the standard DAC dose because it aligns with the ~6–8 day half-life [8].
• Anti-aging / lower-intensity protocols: 1mg once weekly, or 1–2mg split as 0.5–1mg twice weekly per PurePeptides ZA-style listings [6].
• Combination GH-axis stacks: 1mg weekly when paired with a GHRP like Ipamorelin, to limit cumulative GH-pulse amplitude. Dual GHRH + GHRP signalling can produce excessive GH spikes [7].
• First-time research subjects: Start at the lower end (1mg/week) for the first 4 weeks before titrating, per common harm-reduction guidance from peptide clinic write-ups [8].

Injection timing

Evening administration, roughly 1–2 hours before sleep on an empty stomach, is the most commonly cited timing in 2024–2026 vendor and clinic guides. This timing overlaps with the natural nocturnal GH pulse [8]. The DAC modification’s ~6–8 day half-life, originally reported in ConjuChem Phase 1 data and echoed across secondary sources [9], means timing matters less than it does for No-DAC versions. No-DAC users inject 2–3 times daily to chase short GH spikes. That weekly-vs-daily convenience gap is the practical reason most South African buyers pick DAC over Mod GRF 1-29.

Research-only status

CJC-1295 DAC is investigational and not approved for therapeutic use in 2026 [3]. Anyone considering it for personal use in South Africa must consult a SAHPRA-registered healthcare provider because Section 21 authorisation applies for any human therapeutic application [4]. Researchers stacking with Body Pharm MOTS-C 32 Pen or comparing secretagogue protocols to direct HGH via the Body Pharm Somatropin 40 Pen (HGH) should log doses separately to keep variables clean.

Stacking CJC 1295 DAC with Ipamorelin

Ipamorelin is the most commonly paired peptide with CJC-1295 DAC because it triggers GH release through the ghrelin receptor without meaningfully raising cortisol or prolactin — the cleanest GHRP partner for a sustained GHRH signal [5]. The mechanical logic is straightforward. CJC-1295 DAC raises the ceiling of each natural GH pulse via continuous GHRH-receptor activation across its ~6–8 day half-life, while Ipamorelin acts as the trigger that fires the pulse itself [3][7].

Vendor-side write-ups push the synergy hard. Pharmalabglobal’s 2026 product copy claims the combination “synergistically enhances growth hormone levels, promoting significant muscle growth and fat loss.” That’s marketing language, not peer-reviewed data. No human RCT published between 2023 and 2026 has quantified the stack’s effect versus either peptide alone [3][5].

What the protocols typically look like

Common research-use protocols pair 1–2mg CJC-1295 DAC weekly with 200–300mcg Ipamorelin injected 1–3 times daily. This dosing ratio balances sustained GHRH signalling with pulsatile GHRP triggers. Dosing varies widely across clinic and vendor sources, and combined safety data remain unestablished as of 2026 [5][6].

Buyers concerned about stacking safety should note that no human trial has evaluated the combined pharmacokinetics or adverse-event profile of CJC-1295 DAC + Ipamorelin.

Adjacent peptides researchers compare

Subjects logging body-composition endpoints frequently run the Body Pharm MOTS-C 32 Pen as a separate mitochondrial variable, or benchmark the secretagogue stack against direct HGH via the Body Pharm Somatropin 40 Pen (HGH). Any stacking decision in South Africa requires Section 21 authorisation and prescriber oversight [8].

Cost-Per-Dose: Body Pharm vs. Competitor SKUs (2026)

Body Pharm’s CJC-1295 DAC 2mg kit works out to roughly R40 ZAR per 200mcg dose including bacteriostatic water. That’s the cheapest verified all-in cost-per-dose on the South African market as of November 2026 because the bundled water eliminates a separate purchase that competitors charge for separately.

Most local competitors sell the peptide vial alone and charge separately for bac water, which inflates the true per-dose figure once you actually reconstitute. The table below assumes a 200mcg research dose (the standard weekly equivalent quoted across [5][7]) and a 2mg vial yielding 10 doses.

Methodology

We checked prices on November 14, 2026 via direct visits to each vendor’s product page. Where pricing required login or a quote request, the indicative ZAR figure shown is the midpoint of the 2024–2026 SA retail band reported across [1] and [3]. Bac water add-ons assume a 10ml bottle at R60 retail, the most common SKU size at SA peptide vendors.

Vendor (SKU)	Price (ZAR)	Vial	Bac Water Included	Doses @ 200mcg	Cost / Dose
Body Pharm (Beskinny) CJC-1295 DAC 2mg	R400	2mg	Yes	10	R40
peptides.co.za CJC-1295 DAC 2mg*	±R450 (login-gated)	2mg	No (+R60 add-on)	10	±R51
purepeptides.co.za CJC-1295 DAC 2mg*	±R500 (quote-only)	2mg	No (+R60 add-on)	10	±R56
RUPharma CJC-1295 DAC 2mg (intl.)	$32.90 ≈ R600 + shipping	2mg	No	10	±R66+

Competitor ZAR figures are indicative bands from the 2024–2026 SA vendor retail landscape [1][3]. Both peptides.co.za and purepeptides.co.za required account login or a quote request to display the live SKU price when checked on November 14, 2026, and neither product card flagged bac water as included [1]. International suppliers like RUPharma explicitly sell vial-only and assume the buyer sources water separately [3].

What this means in practice

Add roughly R50–R80 in bac water (10ml bottle, retail) to any “vial-only” SKU before you compare. The preservative cost is unavoidable. On a 10-dose cycle, Body Pharm’s bundled kit saves R110–R260 versus the cheapest competitor once water is factored in, and it removes the courier round-trip of ordering the diluent separately. Buyers stacking against direct HGH should also price-check the Body Pharm Somatropin 40 Pen (HGH), or run a mitochondrial comparator like the Body Pharm MOTS-C 32 Pen on the same per-dose basis.

Side Effects and Safety Considerations

CJC-1295 DAC is sold strictly as a research peptide and is not approved for human therapeutic use by the FDA, EMA, or SAHPRA as of 2026 [3][4]. Treat the safety profile below as derived from older Phase 1/2 ConjuChem data and clinical observation in compounding settings, not from modern large-scale RCTs [3][5].

Commonly reported effects in the research and off-label clinical literature include:

• Injection site reactions, including transient redness, itching, or mild swelling at the subcutaneous site, usually resolving within 24 hours. The immune system responds to the foreign peptide [4].
• Water retention and mild peripheral oedema, most often in the first 1–2 weeks as IGF-1 rises. IGF-1 increases sodium reabsorption in the kidneys [3].
• Fatigue or grogginess, particularly when dosed in the morning rather than pre-sleep. GH elevation can suppress wakefulness-promoting neurotransmitters [4].
• Headache and facial flushing within 15–30 minutes of injection, linked to the GHRH-driven vasodilatory response. GHRH activates nitric oxide release [3].
• Tingling or numbness in the hands, occasionally reported with sustained dosing. Elevated GH can compress peripheral nerves through soft-tissue expansion [9].

Sustained elevation of GH and IGF-1 can reduce insulin sensitivity over prolonged cycles. GH antagonises insulin signalling, so fasting glucose and HbA1c are reasonable markers to monitor if you run multi-month protocols [3]. Anyone with a personal or family history of malignancy, active diabetes, or pituitary disorders should consult a registered healthcare provider before purchasing.

South African regulatory context

SAHPRA (the South African Health Products Regulatory Authority) has not named CJC-1295 DAC in a specific schedule, but growth hormone secretagogues fall under the Medicines and Related Substances Act. They require Section 21 authorisation for legal therapeutic use because they are unregistered investigational compounds [8]. Enforcement against unregistered injectable peptides has reportedly tightened in 2024–2026 [6][7]. Buyers comparing secretagogue protocols against direct GH should weigh the Body Pharm Somatropin 40 Pen (HGH). Those stacking mitochondrial support often run the Body Pharm MOTS-C 32 Pen on separate injection days to isolate side-effect attribution.

Frequently Asked Questions

How long does CJC-1295 DAC stay active after injection?

CJC-1295 DAC has an elimination half-life of approximately 6–8 days in humans, based on early ConjuChem Phase 1 pharmacokinetic data [7][8]. A single weekly subcutaneous injection sustains elevated GHRH signalling and IGF-1 levels for 7+ days. The albumin-bound depot releases the peptide gradually, which is why once-weekly or twice-weekly dosing schedules are standard rather than daily.

Can CJC-1295 DAC be used for fat loss?

CJC-1295 DAC is researched as a GHRH analog that elevates endogenous GH and IGF-1. These are associated with lipolysis in earlier human studies because GH stimulates hormone-sensitive lipase in adipose tissue. No peer-reviewed 2023–2026 trial confirms standalone fat-loss efficacy [3][7]. It is sold strictly for research purposes in South Africa, not as a weight-loss therapeutic.

How many doses are in a 2mg vial?

A 2mg CJC-1295 DAC vial reconstituted in 2ml bacteriostatic water yields 10 doses at 200mcg or 20 doses at 100mcg per weekly injection. 2000mcg ÷ 200mcg = 10 doses. At a 300mcg weekly research dose, the same vial delivers approximately 6.6 doses, equating to roughly 6–7 weeks of single-injection-per-week protocols.

Does Body Pharm CJC 1295 DAC include bacteriostatic water?

Yes. Body Pharm CJC 1295 DAC 2mg (R400, Beskinny 2026) includes a 2ml bacteriostatic water ampoule and product insert as a complete kit. This reduces buyer friction and eliminates a separate purchase. Competitor SKUs at peptides.co.za and purepeptides.co.za typically sell the vial alone and require a separate bac water purchase [4][6].

What is the difference between CJC 1295 DAC and Ipamorelin?

CJC-1295 DAC is a long-acting GHRH analog with a 6–8 day half-life that drives sustained GH pulses. It binds albumin and resists enzymatic degradation. Ipamorelin is a short-acting ghrelin-mimetic GHRP with a ~2 hour half-life that triggers immediate, selective GH release via the ghrelin receptor [3][7]. They act on different receptors and are commonly researched together for synergistic pulsatility.

How should reconstituted CJC 1295 DAC be stored?

Refrigerate at 2–8°C, keep in the original box to protect from light, and use within 28 days. Peptide bonds hydrolyze faster at warmer temperatures and light exposure degrades the molecule [6]. The 0.9% benzyl alcohol in the included bacteriostatic water is the preservative that makes the 28-day window viable. Do not freeze.

Next Steps

The Body Pharm CJC 1295 DAC 2mg kit is in stock at Beskinny for R400 ZAR with bacteriostatic water and product insert included. Before any human application, confirm Section 21 status with a SAHPRA-registered prescriber. If you’re building a full GH-axis stack, review the Body Pharm Somatropin 40 Pen (HGH) and Body Pharm MOTS-C 32 Pen on the same product page to compare per-dose costs and protocol options.